Bank of New York Mellon Corp - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 52 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,229,338
-0.4%
99,703
-0.6%
0.00%
Q2 2023$1,233,899
+34.1%
100,317
+34.0%
0.00%
Q1 2023$920,275
+7.2%
74,8800.0%0.00%
Q4 2022$858,124
+460.9%
74,880
+82.9%
0.00%
Q3 2022$153,000
-37.3%
40,9510.0%0.00%
Q2 2022$244,000
-5.8%
40,951
-0.1%
0.00%
Q1 2022$259,000
+61.9%
40,9960.0%0.00%
Q4 2021$160,000
-19.2%
40,9960.0%0.00%
Q3 2021$198,000
-24.4%
40,9960.0%0.00%
Q2 2021$262,000
-1.1%
40,996
-2.9%
0.00%
Q1 2021$265,000
+119.0%
42,225
+140.7%
0.00%
Q4 2020$121,000
+72.9%
17,543
+0.2%
0.00%
Q3 2020$70,000
+20.7%
17,5120.0%0.00%
Q2 2020$58,000
+52.6%
17,512
+0.0%
0.00%
Q1 2020$38,000
-32.1%
17,511
-0.7%
0.00%
Q4 2019$56,000
-29.1%
17,6310.0%0.00%
Q3 2019$79,000
-26.2%
17,6310.0%0.00%
Q2 2019$107,000
-13.0%
17,6310.0%0.00%
Q1 2019$123,000
+75.7%
17,631
-3.4%
0.00%
Q4 2018$70,000
-66.8%
18,255
-57.6%
0.00%
Q2 2018$211,000
-67.0%
43,069
-45.8%
0.00%
Q1 2018$639,000
-22.3%
79,426
-1.0%
0.00%
Q4 2017$822,000
-18.1%
80,210
+16.2%
0.00%
Q3 2017$1,004,00069,0500.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
22NW, LP 749,302$2,892,0001.80%
Clearline Capital LP 316,425$1,221,0000.84%
Newtyn Management, LLC 888,620$3,430,0000.67%
Western Standard LLC 150,363$580,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 222,467$859,0000.40%
BVF INC/IL 721,935$2,787,0000.36%
Sepio Capital, LP 411,676$1,589,0000.12%
Yakira Capital Management, Inc. 66,934$258,0000.09%
J. Goldman & Co LP 152,095$587,0000.04%
Spark Investment Management LLC 48,909$188,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders